---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286126687.md"
description: "Sionna Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results."
datetime: "2026-05-12T15:17:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286126687.md)
  - [en](https://longbridge.com/en/news/286126687.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286126687.md)
---

# 

Sionna Therapeutics shares are trading lower after the company reported worse-than-expected Q1 EPS results.

### Related Stocks

- [SION.US](https://longbridge.com/en/quote/SION.US.md)

## Related News & Research

- [Sionna Therapeutics (SION) Pulls Back On CF Hopes With Valuation Still In Focus](https://longbridge.com/en/news/293289887.md)
- [Sionna Therapeutics Chief Legal Officer Jennifer Fitzpatrick disposes of 10,250 common shares worth $446,862.08](https://longbridge.com/en/news/291975794.md)
- [Sionna Therapeutics Q1 net loss widens, misses estimates](https://longbridge.com/en/news/286086578.md)
- [LifeSci Capital Reaffirms Their Buy Rating on Sionna Therapeutics, Inc. (SION)](https://longbridge.com/en/news/286649459.md)
- [Sionna Therapeutics (NASDAQ:SION) Stock Price Down 10.4% on Disappointing Earnings](https://longbridge.com/en/news/286143885.md)